JMKX001899: Clinical Trials

4 trials of JMKX001899, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Recruiting 1
Phase 31Not yet recruiting 1

Follow JMKX001899: new trials by email Literature Review of JMKX001899 trials Research Report on JMKX001899

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC
JMKX001899, Docetaxel - NSCLC (Non-small Cell Lung Cancer)
Phase 3Not yet recruitingJemincare4722025-12-312025-11-21
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
JMKX001899, IN10018, Chemotherapy: Pemetrexed - NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 1RecruitingJemincare722025-06-062025-07-01
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects
JMKX001899, Placebo - Solid Tumor, Adult
Phase 1UnknownJemincare272024-07-102024-06-25
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
JMKX001899, Itraconazole, Midazolam - Solid Tumor, Adult
Phase 1UnknownJemincare722024-04-012024-04-04

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)

Sponsors

Jemincare (4)

Countries

China (2)

Top investigators

Jie Wang, Doctor (1)  ·  Yilong Wu (1)